Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Multiple Sclerosis |
| Volume | 18 |
| Issue number | 8 |
| Pages (from-to) | 1070-2 |
| Number of pages | 3 |
| ISSN | 1352-4585 |
| DOIs | |
| Publication status | Published - 2012 |
ID: 48584462